-
@ Yahoo! Finance - by layer3.news
2025-05-28 20:14:38
nostr:nprofile1qyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqvap2usgr7nawhqexfk247ap0nfs34jqpjrxqqslrkv3rrrx8aesst3mr8r
✍️ Biogen partners with City Therapeutics to develop a new RNA drug, Grin Therapeutics receives $50 million for its experimental drug, and several biotech companies face setbacks, including Savara, Aurion Biotech, and Prothena.
👉 Biogen partners with City Therapeutics to develop a new RNA drug
👉 Grin Therapeutics receives $50 million for its experimental drug
👉 Savara's drug application is declined by the FDA
👉 Aurion Biotech withdraws its IPO plans
👉 Prothena shelves its late-stage trial for a drug for AL amyloidosis
#JaneGrogan #NedPagliarulo #GwendolynWu #BenFidler #GeneKinney #health
nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqq6yfdmqx50vennpv32c7zx6pfjfnw5mlq6xpr2d9x4kggcevcucsl33ac8